Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
November 04 2016 - 5:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
000-25571
(Commission
File Number)
HORIZON PHARMACEUTICAL LLC
(Exact name of registrant as specified in its charter)
7 Hamilton
Landing, Suite 100
Novato, CA 94949
(415) 408-6200
(Address,
including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock,
$0.001 par value per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
Rule 12g-4(a)(2)
|
|
☐
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
Rule 15d-6
|
|
☐
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Horizon Pharmaceutical LLC (f/k/a Raptor
Pharmaceutical Corp.) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date: November 4, 2016
|
|
|
|
HORIZON PHARMACEUTICAL LLC
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Paul W. Hoelscher
|
|
|
|
|
|
|
Name: Paul W. Hoelscher
|
|
|
|
|
|
|
Title: Executive Vice President, Chief Financial Officer
|
[Signature Page to Form 15]
Raptor Pharmaceutical Corp. (MM) (NASDAQ:RPTP)
Historical Stock Chart
From May 2024 to Jun 2024
Raptor Pharmaceutical Corp. (MM) (NASDAQ:RPTP)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Raptor Pharmaceutical Corp. (MM) (NASDAQ): 0 recent articles
More Horizon Pharmaceutical Llc News Articles